Drug Shortage Report for MULTI 12 INJECTION
Report ID | 129582 |
Drug Identification Number | 02100606 |
Brand name | MULTI 12 INJECTION |
Common or Proper name | MULTI 12 INJECTION |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | ASCORBIC ACID VITAMIN A VITAMIN D VITAMIN B1 VITAMIN B2 NICOTINAMIDE PYRIDOXINE HYDROCHLORIDE DEXPANTHENOL VITAMIN E BIOTIN FOLIC ACID VITAMIN B12 |
Strength(s) | 20MG 660UNIT 40UNIT 0.6MG 0.72MG 8MG 0.8MG 3MG 2UNIT 12MCG 80MCG 1MCG |
Dosage form(s) | LIQUID |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 10 vials of 25ml |
ATC code | B05XC |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Requirements related to complying with good manufacturing practices. |
Anticipated start date | |
Actual start date | 2020-12-03 |
Estimated end date | 2022-07-08 |
Actual end date | 2022-07-12 |
Shortage status | Resolved |
Updated date | 2022-07-13 |
Company comments | Customers can order 44002609 / 6410 MULTI-12 5ML 10LIVI CA / UPC 057513064104 / DIN 02100606 as a substitute. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-12-03 | English | Compare |
v2 | 2020-12-03 | English | Compare |
v3 | 2020-12-03 | French | Compare |
v4 | 2020-12-09 | English | Compare |
v5 | 2020-12-09 | French | Compare |
v6 | 2021-01-19 | English | Compare |
v7 | 2021-01-19 | French | Compare |
v8 | 2021-05-19 | English | Compare |
v9 | 2021-05-19 | French | Compare |
v10 | 2022-03-14 | English | Compare |
v11 | 2022-03-14 | French | Compare |
v12 | 2022-07-12 | English | Compare |
v13 | 2022-07-12 | French | Compare |
v14 | 2022-07-13 | English | Compare |
Showing 1 to 14 of 14